Addex Pharmaceuticals names new CEO
GENEVA, Switzerland — Addex Pharmaceuticals, a biopharmaceutical company specializing in allosteric modulation-based drug discovery and development, has named Dr. Bharatt Chowira as its CEO, according to a press release.
Chowira formerly served as senior vice president and chief operating officer of Nektar Therapeutics.“We are delighted to have Dr. Chowrira take the helm at Addex. Dr Chowrira has achieved much success in his career, including being involved in the turnaround of two biopharmaceutical companies,” said André Mueller, chairman of Addex Pharmaceuticals. “His expertise in R&D operations and corporate development will be a great asset to Addex in our efforts to develop a robust therapeutic pipeline. His leadership and experience will be important in finalizing and implementing a new strategy for the company that will aim to deliver significant value to its shareholders.”